quinacrine has been researched along with EHS Tumor in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, D | 1 |
| Haym, J | 1 |
1 other study available for quinacrine and EHS Tumor
| Article | Year |
|---|---|
[On the problem of a selective thermosensitization of carcinoma cells in vivo with vitamin K3-sodium bisulfite, methylene blue and other thermosensitizers. 2. Studies of an effect of hyperthermia and in-vitro-thermosensitizers on the Yoshida- and Jensen-s
Topics: Animals; Diethylstilbestrol; Fatty Acids, Essential; Fever; In Vitro Techniques; Male; Methylene Blu | 1968 |